# Efficacy and Safety of Lacidofil® STRONG as an Adjuvant for Helicobacter Pylori Treatment in Non-ulcer Dyspepsia

> **NCT04473079** · PHASE2,PHASE3 · COMPLETED · sponsor: **Lallemand Health Solutions** · enrollment: 90 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DIETARY_SUPPLEMENT:** Lacidofil
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT04473079
- **Lead sponsor:** Lallemand Health Solutions
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-16
- **Primary completion:** 2022-06-17
- **Final completion:** 2022-06-17
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2024-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04473079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04473079, "Efficacy and Safety of Lacidofil® STRONG as an Adjuvant for Helicobacter Pylori Treatment in Non-ulcer Dyspepsia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04473079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*